SGTX - Sigilon Therapeutics EPS misses by $0.01 misses on revenue May, 10 2021 04:51 PM Sigilon Therapeutics Inc. Sigilon Therapeutics (SGTX): Q1 GAAP EPS of -$0.60 misses by $0.01.Revenue of $2.96M (-14.7% Y/Y) misses by $0.54M.Press Release For further details see: Sigilon Therapeutics EPS misses by $0.01, misses on revenue